- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Etanercept fusion protein from different biosimilar commercial drugs.
Showing all 3 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Fusion protein |
Erelzi® |
50 mg/mL |
– |
4 mg |
-80°C |
04/2023 |
237,60 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Benepali® |
50 mg/mL |
– |
4 mg |
-80°C |
11/2023 |
264,00 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Nepexto® |
50 mg/mL |
– |
4 mg |
-80 °C |
08/2023 |
264,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin